Indian Journal of Pathology and Microbiology
Home About us Instructions Submission Subscribe Advertise Contact e-Alerts Ahead Of Print Login 
Users Online: 1386
Print this page  Email this page Bookmark this page Small font sizeDefault font sizeIncrease font size

CASE REPORT Table of Contents   
Year : 2010  |  Volume : 53  |  Issue : 1  |  Page : 109-111
Malignant hemangiopericytoma of pituitary fossa

1 Department of Pathology, All India Institute of Medical sciences, New Delhi, India
2 Department of Radiotherapy, All India Institute of Medical sciences, New Delhi, India
3 Department of Neurosurgery, All India Institute of Medical sciences, New Delhi, India

Click here for correspondence address and email

Date of Web Publication19-Jan-2010


Intracranial hemangiopericytomas are rare tumors with aggressive behavior. Other than the meninges, this lesion has rarely been reported in periventricular and sellar region. We report a case of malignant hemangiopericytoma in sellar region in a 47-year-old male who presented with history of sudden onset of bilateral visual disturbances. To best of our knowledge, this is the second case report of malignant hemangiopericytoma in this location. As this intracranial lesion shows aggressive behavior, in the form of recurrence or extracranial metastasis in comparison to its extracranial counterparts, diagnosis should be made cautiously.

Keywords: Hemangiopericytoma, Intracranial, malignant, pituitary fossa, recurrent, sella

How to cite this article:
Das P, Haresh KP, Suri V, Sharma MC, Sharma BS, Sarkar C. Malignant hemangiopericytoma of pituitary fossa. Indian J Pathol Microbiol 2010;53:109-11

How to cite this URL:
Das P, Haresh KP, Suri V, Sharma MC, Sharma BS, Sarkar C. Malignant hemangiopericytoma of pituitary fossa. Indian J Pathol Microbiol [serial online] 2010 [cited 2023 May 30];53:109-11. Available from:

   Introduction Top

Hemangiopericytoma (HPC) denotes lesion having typical thin walled branching vascular pattern with pericytic differentiation of the surrounding tumor cells, which can be ascertained by immunohistochemical stains. [1] This tumor has commonly been described in deep soft tissue, especially in pelvis, retroperitonium and proximal lower limbs. Intracranial HPCs are very rare, accounting for less than 1% of primary central nervous system (CNS) tumors and constitute 2% to 4% of meningeal tumors. [2],[3] Since the first report of CNS HPC in 1954, most of these have been reported to be originating in meninges and around ventricles. [3],[4],[5] Incidence in pituitary fossa is particularly very rare. [5],[6],[7],[8],[9],[10] In the literature studied, only one case of a hemangiopericytic meningioma found arising in this location is reported. [11] We describe a primary malignant HPC of pituitary fossa in a 47-year-old male. This is the second case report of primary malignant HPC of pituitary fossa to the best of our knowledge.

   Case Report Top

A 47-year-old male presented with a history of sudden onset of headache and progressive deterioration of vision in both eyes; left worse than right, of one month duration. There was no history of vomiting, seizures, loss of consciousness, weakness in limbs or urinary disturbance.

On examination, both pupils were normal in size and reacting to light. Examination for vision showed that with the right eye he was able to count fingers at a distance of five feet; while with the left eye he was able to count fingers only at a distance of one foot. There were bitemporal field cuts by confrontation technique. No cranial nerve deficit or motor or sensory deficit was identified.

A routine complete hemogram and biochemical tests including liver and kidney function tests were within normal range. Magnetic resonance imaging (MRI) of the brain was performed, which showed a large well defined lobulated dumb-bell shaped mass of 30x25x22 mm size arising from the pituitary fossa and extending into the suprasellar region. It was hypo-intense on T1 weighted image and hyper-intense on T2 weighted image. The tumor was encasing the optic chiasm [Figure 1]. Cavernous sinus extension was not identified. The tumor showed dense and uniform enhancement with intravenous gadolinium. Radiologically possibility of a malignant pituitary tumor was suggested. A detailed hormonal study was done: T3-<40 (normal range-70-170); T4-6.9 (normal range 45-125); TSH- 0.045 (normal range- 0.4-4); prolactin-<0.5 (normal range- 0-50); growth hormone -<0.05 (normal range 0.5); cortisol-14.3 (normal range- 5-25).

He underwent surgery by a sub-labial trans-sphenoidal approach. Per-operatively, there was a brownish gray, moderately vascular, easily suckable tumor in the sella. The tumor was seen to erode the sella and extend into sphenoid sinus. The tumor was excised and floor was repaired with fascia glue. Histopathological examination revealed a cellular tumor with densely packed round to spindled cells with peri-cellular reticulin patterns along with interspersed numerous staghorn blood vessels lined by endothelial cells [Figure 2]a. The tumor cells showed moderate nuclear pleomorphism [Figure 2]d, focal necrosis [Figure 2]b and a high mitotic activity [>10/ 10 HPF] [Figure 2]d. Focal collagen formation was noted [Figure 2]c. The tumor cells were immune-positive for vimentin and CD 34 [Figure 2]e and negative for cytokeratin, epithelial membrane antigen (EMA), bcl2, smooth muscle actin (SMA), chromogranin and synaptophysin. MIB-1 labeling index was high (15-18%) [Figure 2]f.

Post operatively, headache improved but the vision in both eyes deteriorated and the left eye had only perception of light at one meter. Postoperative MRI (15 days post op) revealed residual tumor in the suprasellar region 20x14x11 mm with intra-lesional hemorrhage and perilesional edema [Figure 3]. The patient was taken up for postoperative radiotherapy. He received 60 Gray in 30 fractions over six weeks of external beam radiotherapy by three dimensional conformal techniques with right and left lateral and vertex fields on linear accelerator from October 2007 to November 2007 [Figure 4]. Since then the patient is doing well and showed no recurrence on follow-up.

   Discussion Top

The term HPC was first used to depict a malignant vascular tumor, arising from pericytes (Zimmerman's' pericytes). [2] Gradually it became clear that, about 70% (or probably more) of the HPCs are benign (WHO grade II), and the rest behave in malignant fashion. There is variability of the criterions of malignancy. While for some authors tumor size > 5 centimeter, mitotic figures > 4/ 10 HPF, cellular pleomorphism and necrosis, are features indicating malignancy, [1] in the World Health organization (WHO) book on CNS tumors features of anaplasia (WHO grade III) have been described as mitotic figure of 5/ 10 HPF and/or necrosis along with any two of the following criteria: hemorrhage, moderate to high nuclear atypia and increased cellularity. [2] According to these criteria our case fits satisfactorily with malignant HPC.

Though it is difficult to differentiate HPCs from its related entities like solitary fibrous tumor (SFT), characteristic histomorphology and immunohistochemical findings are often helpful. [11] Based on morphological features alone, meningioma, SFT, monophasic synovial sarcoma or infantile fibrosarcomas come into differential diagnosis. Considering the rare location of the present tumor, pituitary adenomas, meningiomas and SFT may be considered as differential diagnosis. In our case, lack of continuity with meningeal surface, whorling and negativity for EMA helped differentiate it from meningioma; absence of stromal hyalinization, variable cellularity, immunonegativity for SMA and bcl2 helped differentiate it from SFT. [11] Neither was there positivity for neuroendocrine markers to indicate presence of pituitary tissue, nor was there any elevation of serum pituitary hormone levels. Thus the possibility of a dedifferentiated pituitary malignancy was ruled out.

Intracranial HPCs is one of the few primary brain tumors, which metastasize outside the central nervous system. [3] Local recurrence is not uncommon and has been noted at an average interval of 50 months after application of radiotherapy. Recurrence can be seen as late as nine years (Han et al. [6] ). In literature, recurrence rates reported at 5, 10 and 15 years were 65%, 76% and 87% respectively. [1],[6],[12] In the index case the patient was being followed up since 11 months with no sign of recurrence.

Reporting HPC in pituitary fossa needs emphasis due to its rarity and the extent to which it may impose difficulty in making a diagnosis either preoperatively or radiologically. Till date, only around five to six cases of HPCs in the sellar region have been reported, with only one example of recurrent angioblastic meningioma in this location [Table 1]. Most of the intracranial HPCs reported till date, are seen arising either from meninges or in and around the ventricles. [3],[4],[5],[6] While diagnosing an intracranial HPC, special attention should be given to identify the features of malignancy, if any. Our report shows that even malignant HPC can be seen in this site, and in such a case a diligent surgery followed by radiosurgical approach may prove fruitful. [12]

   References Top

1.Guillou JA, Fletcher CD, Fletcher, Mandahl N. In: Fletcher CD, Unni KK, Mertens F, editors. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of Soft Tissue and Bone. Lyon: IARC Press; 2002. p. 86.  Back to cited text no. 1      
2.Gianni C, Reushing EJ. Hainfellaer in hemangiopericytoma. In: Louis DN, Ihgaki H, Wiestler OD, Cavenee WK, editors. WHO classification of tumors of central nervous system. Lyon: IARC; 2007. p. 178-80.  Back to cited text no. 2      
3.Gutheri BL, Ebersold MJ, Schithauer BW, Shaw EG. Meningeal hemangiopericytomas: histological features, treatment and long term follow-up of 44 cases. Neurosurgery 1989;25:514-22.  Back to cited text no. 3      
4.Begg CF, Garret R. Hemangiopericytoma occurring in meninges, case report. Cancer 1954;7:602-6.  Back to cited text no. 4  [PUBMED]    
5.Deasi K, Nadkarni T, Fattepurker S, Goel A, Shenoy A, Chitle A, et al. Hemangiopericyoma in the trigone of lateral ventricle- case report. Neurol Med Chir (Tokyo) 2004;44:484-8.  Back to cited text no. 5      
6.Han MH, Cho YD, Kim YD, Kim DH. Recurrent Sellar and Suprasellar Hemangiopericytoma. J Korean Neurosurg Soc 2007;41:425-8.  Back to cited text no. 6      
7.Morrison DA, Bibby K. Sellar and suprasellar hemangiopericytoma mimicking pituitary adenoma. Arch of Ophthal 1997;115:1201-3.  Back to cited text no. 7      
8.Mangiardi JR, Flamm ES, Cravioto H, Fisher B. Hemangiopericytoma of the pituitary fossa: case report. Neurosurg 1983;13:58-62.  Back to cited text no. 8      
9.Yokota M, Tani E, Maeda Y, Morimura T, Kakudo K, Uematsu K. Acromegaly associated with suprasellar and pulmonary hemangiopericytomas. Case report. J Neurosurg 1985;62:767-71.   Back to cited text no. 9      
10.Jalali R, Srinivas C, Nadkarni T, Rajasekharan P. Suprasellar haemangiopericytoma challenges in diagnosis and treatment. Acta Neurochirurgica 2008;150:67-71.  Back to cited text no. 10      
11.Tihan T, Viglione M, Rosenblum MK, Olivi A, Burger PC. Solitary fibrous tumors in the central nervous system. A clinicopathologic review of 18 cases and comparison to meningeal hemangiopericytomas. Arch Pathol Lab Med 2003;127:432-9.  Back to cited text no. 11      
12.Du G, Zhou L, Li S, Mao Y, Chen H. Management of hemangiopericytomas in central nervous system. Chin Med J (Engl) 2001;114:795-8.  Back to cited text no. 12  [PUBMED]  [FULLTEXT]  

Correspondence Address:
Vaishali Suri
Neuropathology laboratory, Department of Pathology, All India Institute of medical Sciences, Academic Building, New Delhi - 110 029
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0377-4929.59196

Rights and Permissions


  [Figure 1], [Figure 2], [Figure 3], [Figure 4]

  [Table 1]

This article has been cited by
1 Skull base hemangiopericytomas
Samuel Tobias, Shady Jahshan, Yuval Grober, Jean F. Soustiel
Acta Neurologica Belgica. 2021;
[Pubmed] | [DOI]
2 Solitary Fibrous Tumor or Hemangiopericytoma of the Sella in an Older Patient Treated with Partial Removal Followed by Fractionated Gamma Knife Radiosurgery
NMC Case Report Journal. 2021; 8(1): 697
[Pubmed] | [DOI]
3 Supraorbital Craniotomy for Sellar Solitary Fibrous Tumor: Operative Technique and Literature Review
Arun Gunasekaran, Jaime Martinez Santos, William Alexander Vandergrift
World Neurosurgery. 2020; 141: 395
[Pubmed] | [DOI]
4 Solitary Fibrous Tumor of the Central Nervous System
Michele Bisceglia, Carlos Galliani, Giuseppe Giannatempo, Walter Lauriola, Mario Bianco, Vincenzo D'Angelo, Stefano Pizzolitto, Giulia Vita, Gianandrea Pasquinelli, Gaetano Magro, David Ben Dor
Advances in Anatomic Pathology. 2011; 18(5): 356
[Pubmed] | [DOI]
5 Hemangiopericytoma of the pineal region
Hasturk, A.E., Basmaci, M., Bozdogan, N., Canbay, S.
Neurosciences. 2011; 16(2): 159-161
6 Solitary fibrous tumor of the central nervous system: A 15-year literature survey of 220 cases (August 1996-July 2011)
Bisceglia, M., Galliani, C., Giannatempo, G., Lauriola, W., Bianco, M., DęAngelo, V., Pizzolitto, S., (...), Dor, D.B.
Advances in Anatomic Pathology. 2011; 18(5): 356-392


    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Email Alert *
    Add to My List *
* Registration required (free)  

    Case Report
    Article Figures
    Article Tables

 Article Access Statistics
    PDF Downloaded221    
    Comments [Add]    
    Cited by others 6    

Recommend this journal